Stone House Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.9K | Sell |
74
-25
| -25% | -$11.1K | 0.01% | 182 |
|
|
2025
Q1 | $48K | Buy |
+99
| New | +$48K | 0.01% | 150 |
|
|
2024
Q4 | – | Sell |
-124
| Closed | -$57.7K | – | 351 |
|
|
2024
Q3 | $57.7K | Hold |
124
| – | – | 0.01% | 108 |
|
|
2024
Q2 | $58.1K | Hold |
124
| – | – | 0.02% | 113 |
|
|
2024
Q1 | $51.8K | Hold |
124
| – | – | 0.01% | 127 |
|
|
2023
Q4 | $50.5K | Hold |
124
| – | – | 0.02% | 86 |
|
|
2023
Q3 | $43.1K | Hold |
124
| – | – | 0.02% | 86 |
|
|
2023
Q2 | $43.6K | Hold |
124
| – | – | 0.02% | 87 |
|
|
2023
Q1 | $39.1K | Buy |
+124
| New | +$39.1K | 0.01% | 97 |
|